(VIANEWS) – Cronos Group (NASDAQ: CRON) saw its share price surge 26.4% over 10 sessions, from EUR1.97 on March 12th to EUR2.49 at 00:24 EST on Tuesday morning – this in contrast to broader market performance which fell 0.27% following on from its downward trend from previous session – Cronos Group closed with EUR2.49 marking 5.68% less than its 52-week high of EUR2.64.
About Cronos Group
Cronos Group Inc. is an innovative cannabinoid company with global reach that specializes in the cultivation, production and marketing of premium cannabis products. Operating across three key markets – Canada, Israel and Germany – the company offers products under their Spinach, Lord Jones and PEACE NATURALS brands including dried flower, pre-rolls, oils vaporizers edibles cannabis tinctures. Founded in 2012 in Toronto Canada by CEO Christopher Leeson Cronos Group Inc has quickly established itself as an influential player within a rapidly expanding cannabis industry
Yearly Analysis
Cronos Group Inc, a Canadian cannabis company, trades on both Euronext Amsterdam and NASDAQ Global Select Market under the symbol “CRON”. As of 00:28 EST its stock was currently worth EUR2.49; which was below its 52-week high of EUR2.64 but significantly above its low of EUR1.64.
Cronos Group anticipates sales growth of 15.1% this year and 14.1% in 2019. Their EBITDA (Earnings Before Interest, Taxes Depreciation and Amortization) currently stands at -1.17; thus indicating negative earnings.
Given this information, investors should carefully evaluate Cronos Group’s growth potential and financial health before making their investment decision. Additional research may also prove beneficial before making final investment decisions.
Technical Analysis
Cronos Group’s stock is currently experiencing an upward trajectory, as evidenced by its price being above both its 50-day and 200-day moving averages of EUR2.09 and EUR1.96, respectively. This trend is further strengthened by increased trading volume; currently standing at 6338028 which is 162.87% above its average volume of 2375240 and indicative of investor enthusiasm towards Cronos’ shares.
Volatility for this stock has also increased, with its current intraday variation average sitting at 4.51% for the past week, 0.76% for the past month, and 2.53% for the quarter. Among those three periods, average volatility reached its highest amplitude during those three periods – 4.51% during last week; 2.77% during month, 2.53% during quarter.
According to the stochastic oscillator, an industry standard tool for identifying overbought and oversold conditions, Cronos Group stock is currently considered oversold (=20). This could indicate an opportunity for growth within Cronos Group stock that could lead to price gains in the near future.
Due to these developments, investors may wish to keep a close watch on Cronos Group as it navigates the ever-evolving stock market landscape.
Quarter Analysis
Sales GrowthCronos Group has witnessed robust sales growth for both the current and upcoming quarters, with 18.6% for this quarter and 29.3% in the next.
Cronos Group has experienced year-over-year revenue growth of 8.5% during its most recent twelve trailing months, totalling an impressive total revenue figure of 87.24M.
Equity Analysis
However, other considerations must also be taken into account such as growth prospects and competitive positioning when valuing stocks. Analyst RecommendationsAs of my knowledge cutoff date of September 2021, there were no analyst recommendations available for Cronos Group. Analyst recommendations may change over time and should be carefully evaluated along with other factors when making investment decisions.When investing in Cronos Group, as with any investments there are risks and uncertainties involved. These could include market risk, regulatory risk, operational risk or others; it’s essential for investors to carefully consider these potential issues as well as assess their personal risk tolerance before making their final investment decisions.
More news about Cronos Group (CRON).
